Jaguar Health (NASDAQ:JAGX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell?

Jaguar Health, Inc. (NASDAQ:JAGX)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.42 and traded as low as $0.85. Jaguar Health shares last traded at $0.85, with a volume of 358,850 shares.

Jaguar Health Trading Down 1.7 %

The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. The business has a 50 day moving average price of $1.00 and a 200-day moving average price of $1.39.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned about 0.22% of Jaguar Health as of its most recent SEC filing. 12.04% of the stock is currently owned by hedge funds and other institutional investors.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.